Profile
Presently, Pat Cotroneo is Chief Financial Officer & Senior VP-Finance at FibroGen, Inc. Mr. Cotroneo previously occupied the position of Controller for Systemix, Inc. and Controller at Genetic Therapy, Inc. He received an undergraduate degree from the University of San Francisco.
Former positions of Pat Cotroneo
| Companies | Position | End |
|---|---|---|
| FIBROGEN, INC. | Director of Finance/CFO | 2021-09-06 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Comptroller/Controller/Auditor | 1999-12-31 |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Comptroller/Controller/Auditor | 1999-12-31 |
Training of Pat Cotroneo
| University of San Francisco | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Stock Market
- Insiders
- Pat Cotroneo
